Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Gross Margin (2020 - 2025)

SOPHiA GENETICS's Gross Margin history spans 6 years, with the latest figure at 67.68% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 56.0% to 67.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 67.4%, a 2.0% decrease, with the full-year FY2025 number at 67.4%, down 2.0% from a year prior.
  • Gross Margin hit 67.68% in Q4 2025 for SOPHiA GENETICS, up from 66.32% in the prior quarter.
  • Over the last five years, Gross Margin for SOPH hit a ceiling of 71.96% in Q4 2022 and a floor of 61.21% in Q2 2021.
  • Historically, Gross Margin has averaged 66.36% across 5 years, with a median of 66.85% in 2023.
  • The widest YoY moves for Gross Margin: up 6317bps in 2021, down -583bps in 2021.
  • Tracing SOPH's Gross Margin over 5 years: stood at 62.45% in 2021, then grew by 15bps to 71.96% in 2022, then decreased by -3bps to 69.79% in 2023, then dropped by -2bps to 68.25% in 2024, then dropped by -1bps to 67.68% in 2025.
  • Business Quant data shows Gross Margin for SOPH at 67.68% in Q4 2025, 66.32% in Q3 2025, and 66.97% in Q2 2025.